Related Experiment Video

Updated: Jan 20, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
05:06

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis

Published on: October 24, 2015

12.8K

MicroRNA-2053 overexpression inhibits the development and progression of hepatocellular carcinoma

Tao Song1, Ke Ma2, Cui Zhao3

  • 1Department of Medical Imaging, Changhai Hospital of Second Military Medical University of Chinese PLA, Shanghai 200433, P.R. China.

Oncology Letters
|August 20, 2019
PubMed

Insights

MicroRNA 2053 (miR-2053) acts as a tumor suppressor in hepatocellular carcinoma (HCC). Overexpression of miR-2053 inhibits HCC cell growth and spread by targeting key cancer signaling pathways.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs crucial for gene regulation, including in cancer development.
  • The specific roles of many miRNAs in tumor progression remain unclear, necessitating further investigation.
  • Hepatocellular carcinoma (HCC) is a significant global health concern with complex regulatory mechanisms.

Purpose of the Study:

  • To investigate the functional role of miR-2053 in hepatocellular carcinoma (HCC) cells.
  • To elucidate the impact of altered miR-2053 expression on HCC cell behavior.
  • To identify the molecular pathways targeted by miR-2053 in HCC.

Main Methods:

  • Utilized a HCC cell line to study the effects of miR-2053 overexpression and knockdown.
  • Assessed cellular phenotypic changes including proliferation, migration, invasion, and apoptosis.
  • Investigated the modulation of phosphoinositide 3-kinase (PI3K) and Wnt/β-catenin signaling pathways.

Main Results:

  • miR-2053 overexpression suppressed HCC cell proliferation, migration, and invasion.
  • miR-2053 overexpression promoted apoptosis in HCC cells.
  • miR-2053 knockdown led to opposite phenotypic changes, confirming its suppressive role.
  • Mechanistically, miR-2053 overexpression downregulated the PI3K and Wnt/β-catenin signaling pathways.

Conclusions:

  • miR-2053 functions as a tumor suppressor in hepatocellular carcinoma.
  • miR-2053 inhibits HCC proliferation, migration, and invasion by targeting the PI3K and Wnt/β-catenin pathways.
  • miR-2053 holds potential as a therapeutic agent for HCC treatment.
Keywords:
WntinvasionmicroRNA-2053migrationphosphoinositide 3-kinaseproliferation

More Related Videos

Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo10:18

Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo

Published on: September 11, 2018

6.2K
Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

2.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K